As popularity of cosmetic injection treatments expands, demand for safer, less painful and more accurate delivery systems grows LIVINGSTON, NJ MLSS, (Marketwired) 11/20/17 Milestone Scientific Inc . (NYSE American: MLSS) (NYSE MKT: MLSS), a leading developer of computerized drug delivery instruments that deliver painless and precise injections, today announced plans for the commercial launch of its novel and proprietary cosmetic injection instrument for delivery of botulinum toxin (such as Botox® and Dysport®). Key highlights of the new cosmetic instrument include: Improved needle
http://bit.ly/2jbkvtl
No comments:
Post a Comment